Rapid PE Triage and Notification (PETN)

by RapidAI (formerly iSchemaView)  · Based in United States → — Accelerate your PE care pathways
Cardiology Emergency Medicine Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

Rapid PE Triage and Notification (PETN) is a radiological computer-aided triage and notification software developed by RapidAI (formerly iSchemaView). It is designed to assist hospital networks and trained clinicians in workflow triage by flagging and communicating suspected positive findings of central pulmonary embolism (PE) pathology in adults.

The device analyzes CTPA images, utilizing an AI/ML module to identify potential central PEs. It operates within the integrated Rapid Platform, providing priority notifications to clinicians. These real-time notifications, which can include compressed preview images (not for diagnostic use), are delivered to physicians via PACS, email, or the Rapid Mobile app, enabling faster triage and care team alignment. The software is intended to be used on single-energy exams and functions in parallel with the standard of care.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI/ML module for CTPA image analysis
  • Detection of suspected central pulmonary embolism (PE)
  • Workflow triage and prioritization
  • Real-time notifications to clinicians (PACS, email, mobile app)
  • Compressed preview images (not for diagnostic use)
  • Operates in parallel with standard of care
  • Integration within the Rapid Platform
  • Mobile and desktop application access
  • In-app messaging for care team coordination
  • Customizable notifications based on clinical thresholds

Use Cases

  • Accelerating pulmonary embolism (PE) care pathways
  • Workflow triage for suspected central PE cases
  • Real-time notification of suspected PE findings
  • Coordinating care teams for PE patients
  • Assisting in diagnosis and treatment planning for PE
  • Automated data collection and research for PE metrics

What Physicians Need to Know

Cardiac CT/MRI Analysis
Rapid PE Triage and Notification (PETN) is designed to identify suspected central pulmonary embolisms (PE) on CT pulmonary angiogram (CTPA) images. It has demonstrated high sensitivity (94%) and specificity (93%) for central PE detection on CT scans. The module's diagnostic performance is consistent across CT scanners from various manufacturers. The tool also includes Rapid PE RV/LV, which provides comparative cross-sectional CT images showing anatomical structures. While the primary focus is on CTPA for PE detection, the broader RapidAI platform offers solutions for cardiac and vascular conditions, including aortic AI for analyzing CT scans to find patients, track changes, and provide measurements.
Real-Time Alert Capability
The Rapid PE Triage & Notification system provides real-time notifications to physicians when a suspected central PE is identified. This capability aims to speed up patient triaging and alert care teams, ultimately reducing the time to treatment. The system integrates AI results, source imaging, and clinical data, along with communication tools, into a single platform.
AHA/ACC Guideline Alignment
The 2026 AHA/ACC guideline for acute PE emphasizes objective risk stratification, rapid multidisciplinary coordination, and appropriate triage. The guideline introduces a new 5-tier clinical classification scheme for PE severity and prognosis. It strongly recommends the use of PE Response Teams (PERT) for patients with increased risk for adverse outcomes to improve in-hospital care delivery. The guideline also recommends immediate initiation of anticoagulation therapy for acute PE patients without contraindications.
Heart Failure Risk Prediction
While Rapid PE Triage and Notification focuses on PE detection, risk stratification for PE often involves assessing factors that can impact cardiac function. The AHA/ACC guideline for acute PE recommends measuring lactate in patients with AHA/ACC PE Categories C-E to risk stratify for short-term complications and/or mortality. Additionally, the Pulmonary Embolism Severity Index (PESI) and simplified PESI (sPESI) are validated scores for mortality prediction in PE patients. Research suggests combining CT findings of right ventricular dysfunction (RVD) with the PESI score can improve predictive accuracy for adverse outcomes in acute PE. Point-of-care echocardiography can also be a useful diagnostic tool to detect RVD.
Physician Tip

Rapid PE Triage and Notification (PETN) is a valuable AI tool for expediting the identification and management of central pulmonary embolisms. Physicians should leverage its real-time notification capabilities to quickly assess suspected PE cases and activate Pulmonary Embolism Response Teams (PERT) for timely intervention. The high sensitivity and specificity of the AI for central PE detection on CTPA scans can enhance diagnostic confidence and streamline workflows. Integrating the AI's findings with clinical context and patient-specific risk factors, as outlined in AHA/ACC guidelines, is crucial for optimal patient care. The tool's ability to automate data collection and provide analytics can also be utilized to refine PE programs and improve outcomes over time.

The Rapid PE Triage and Notification module is designed to integrate AI results, source imaging, and clinical data into a single platform, facilitating seamless communication among care teams. It supports automated data collection via EHR integration, which can be used for tracking and analyzing PE metrics and patient data. The system is intended to work in conjunction with Rapid Workflow for PE to manage the entire patient care journey.

Details

Category Cardiology AI, Radiology & Imaging AI, Triage & ER/ICU AI
Pricing Contact for pricing
DeploymentOn-premise Rapid Server (dedicated or virtual) within hospital LAN/firewall, or Rapid Edge Cloud Platform.
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Cardiology, Emergency Medicine, Radiology

What the Web Says

Rapid PE Triage and Notification (PETN) is an AI-powered software designed to quickly identify suspected central pulmonary embolisms (PE) from CT pulmonary angiography (CTPA) scans and notify physicians in real-time. This aims to streamline communication among care teams, accelerate triage, and potentially improve patient outcomes by reducing the time to treatment. Studies have shown the PETN module to have high sensitivity and specificity for detecting central PE, performing consistently across different CT scanner manufacturers and patient demographics.

Overall: Positive

Strengths

  • Rapid identification of suspected central PE on CTPA images.
  • Real-time notifications to physicians via various devices, enhancing communication and workflow.
  • High sensitivity (94%) and specificity (93%) for central PE detection.
  • Consistent diagnostic performance across different CT scanner manufacturers and patient age groups.
  • Potential to reduce crucial time intervals in PE care and improve workflow efficiencies.
  • Aids in prioritizing patients and accelerating decision-making for treatment.

Limitations

  • Limited independent reviews from platforms like G2, Capterra, or Reddit specifically for PETN.
  • While studies show high accuracy, AI tools are intended to complement, not replace, clinician interpretation.
  • The impact on many important clinical outcomes, such as patient harms, mortality, and quality of life, is still uncertain due to limitations in available evidence.
  • Cost-effectiveness of the solution is currently unknown.
  • Potential for false negatives, meaning physicians need to be cognizant when using these applications.

Based on reviews from: rapidai.com, nih.gov, auntminnie.com, diagnosticimaging.com, mobihealthnews.com, businesswire.com, massdevice.com, aihealthcarenow.com, venousnews.com, fda.gov, canjhealthtechnol.ca, capterra.com, g2.com, interventionalnews.com, slashdot.org, sourceforge.net, youtube.com, reddit.com

Last updated: 2026-10-30

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Rapid PE Triage and Notification (PETN)

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Financial Post
RapidAI Enhances Pulmonary Embolism Care
RapidAI's PE triage and notification product, combined with its workflow and communication tools, aims to improve pulmonary embolism care by notifying clinicians of suspected PE.
2023-02
MassDevice
FDA clears RapidAI pulmonary embolism diagnostic, triage tech
RapidAI received FDA 510(k) clearance for its Rapid RV/LV tool, which is part of the Rapid PE triage and notification product, to assess pulmonary embolism severity by calculating the right ventricle to left ventricle ratio.
2023-02
DAIC (Diagnostic and Interventional Cardiology)
RapidAI Receives FDA 510(k) Clearance for Pulmonary Embolism Product
RapidAI announced FDA 510(k) clearance for Rapid RV/LV, an addition to its Rapid PE solution, which helps physicians quickly assess PE severity by calculating the RV/LV ratio from CTPA images.
2023-02
Medical Product Outsourcing (MPO)
FDA Clears RapidAI's ...
RapidAI received U.S. FDA clearance for its technology, which includes the Rapid PE triage and notification product.
2023-04
Physician AI Tools
Rapid PE Triage and Notification (PETN)
Rapid PE Triage and Notification (PETN) by RapidAI is an AI-powered software that analyzes CTPA images to quickly identify suspected central pulmonary embolisms and notify clinicians, thereby streamlining workflows.
2026-10
AI Healthcare Now
Healthcare Operations AI
Rapid PE Triage and Notification (PETN) by RapidAI is listed among cleared products in healthcare AI intelligence.
2026-10
National Institutes of Health (NIH)
Rapid PE Triage and Notification
Rapid PE Triage and Notification, developed by iSchemaView Inc. (now RapidAI), is a radiology tool that uses CT analysis for PE and workflow/triage, with an algorithm that detects central PE on CT and assists with workflow triage through flagging and notification.
2022

Videos

Product demos, reviews, and walkthroughs for Rapid PE Triage and Notification (PETN).

Loading videos...

View all on YouTube

Frequently Asked Questions

Rapid PE Triage and Notification (PETN) helps cardiologists by automatically analyzing CT pulmonary angiogram (CTPA) images to identify suspected central pulmonary embolisms and then delivering real-time notifications to the care team. This expedites patient triage and aligns care teams more quickly, reducing the overall time to treatment for PE patients.
A multicenter retrospective study involving over 1,000 CT scans showed that the PETN module had an overall sensitivity of 94% and specificity of 93% for central PE. This diagnostic performance was consistent across different CT scanner manufacturers and various age groups.
While AI tools like PETN can significantly improve workflow and speed up identification, they are intended to complement, not replace, a clinician's interpretation of medical imaging. The impact of AI on certain patient outcomes is still being studied, and there's a need for more robust research to fully understand its benefits and potential harms across diverse patient populations.
Rapid PE Triage and Notification integrates seamlessly with existing hospital IT infrastructure, including PACS, EHR systems, and communication platforms. This allows for automated processing of images from scanners, delivery of results to PACS and mobile apps, and facilitates communication among care teams without disrupting normal workflows.
Yes, other companies also offer AI-powered solutions for PE detection. For example, Viz.ai has a PE Module that has shown to reduce time-to-assessment and anticoagulation, and Aidoc also has an FDA-cleared AI pulmonary embolism screening tool designed to flag potential cases of PE incidentally detected in CT scans.
Rapid PE Triage and Notification has received FDA 510(k) clearance. It is classified as Radiological Computer-Assisted Triage and Notification Software.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

More from RapidAI (formerly iSchemaView)

iSchemaView RAPID
RapidAI (formerly iSchemaView)
Neurology AI
RapidAI is an AI-enabled software platform that facilitates the viewing, processing, and analysis of CT and MRI imaging to aid clinicians in assessing patients with suspected stroke, providing automated results for faster, more accurate diagnostic and treatment decisions.
Rapid
RapidAI
Neurology AI
RapidAI is an AI-driven medical imaging analysis and coordinated care platform that empowers healthcare teams to rapidly, precisely, and confidently manage life-threatening conditions, especially acute stroke, through advanced CT and MRI image processing.
Rapid CTA 360
RapidAI
Neurology AI
Rapid CTA 360 by RapidAI (formerly iSchemaView) is an AI-powered imaging solution providing automated 3D CTA reconstructions for rapid and precise stroke diagnosis and treatment planning, enhancing visibility of occlusions and collateral flow.
Rapid LVO
RapidAI (formerly iSchemaView)
Neurology AI
Rapid LVO by RapidAI is an FDA-cleared AI tool for the fast and accurate detection of Large Vessel Occlusions (LVOs) in acute stroke patients using CTA imaging, streamlining triage and care coordination.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.